MYC and hepatocellular carcinoma: Specifically, K48-linked polyubiquitination plays a critical role in hepatocellular carcinoma by promoting the degradation of c-Myc and enhancing glucose metabolism reprogramming in tumor cells (Xia et al., 2023).